Literature DB >> 27240831

Ellagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production.

Gamal Allam1,2, Abdelaziz S A Abuelsaad1,2, Mohammed A Alblihed1, Adnan A Alsulaimani3.   

Abstract

CONTEXT: The main immunopathology in schistosomiasis mansoni consists of a granulomatous inflammatory and fibrosing reaction in the liver and intestine against tissue trapped parasite eggs, which is mediated by CD4(+ )T cells. Ellagic acid (EA), a natural phenolic compound found in fruits and nuts, has potent anti-oxidant and anti-inflammatory properties.
OBJECTIVE: The aim of the present study was to evaluate the potential effect of EA in the treatment of murine schistosomiasis mansoni and its induced immunopathology.
MATERIALS AND METHODS: Mice were infected, each with 40 Schistosoma mansoni (S. mansoni) cercariae and treated with EA at a total dose of 600 mg/kg body weight. At week eight of infection, mice were sacrificed; worm and egg burden were estimated; hepatic granuloma volume and collagen fibers deposition were evaluated; splenocytes were prepared and cultured in the presence of S. mansoni antigens.
RESULTS: EA treatment did not show any significant effect on worm or egg burden. However, hepatic granuloma volume and collagen fibers deposition were largely reduced with EA treatment. EA treatment augmented specific IL-10 production in response to S. mansoni antigenic stimulation. However, specific IL-1β, IL-4, IL-12, IL-13, IL-17A, TNF-α and IFN-γ production were significantly reduced with ex vivo and in vivo EA treatment. Serum IgM and IgG levels significantly increased, whereas specific IgA and IgE levels did not significantly change with EA treatment.
CONCLUSION: EA treatment modulates cellular and humoral immune responses of infected mice and leads to a significant reduction of liver pathology in acute murine schistosomiasis mansoni.

Entities:  

Keywords:  Antibody response; Schistosomiasis mansoni; cytokine response; ellagic acid; immunopathology

Mesh:

Substances:

Year:  2016        PMID: 27240831     DOI: 10.1080/08923973.2016.1189561

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  5 in total

1.  Immunomodulatory Properties of Pomegranate Peel Extract in a Model of Human Peripheral Blood Mononuclear Cell Culture.

Authors:  Miodrag Čolić; Marina Bekić; Sergej Tomić; Jelena Đokić; Dušan Radojević; Katarina Šavikin; Nataša Miljuš; Milan Marković; Ranko Škrbić
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

2.  Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.

Authors:  Ulrich Membe Femoe; Hermine Boukeng Jatsa; Valentin Greigert; Julie Brunet; Catherine Cannet; Mérimé Christian Kenfack; Nestor Gipwe Feussom; Joseph Bertin Kadji Fassi; Emilenne Tienga Nkondo; Ahmed Abou-Bacar; Alexander Wilhelm Pfaff; Théophile Dimo; Pierre Kamtchouing; Louis-Albert Tchuem Tchuenté
Journal:  PLoS Negl Trop Dis       Date:  2022-04-21

3.  Liposomal Ellagic Acid Alleviates Cyclophosphamide-Induced Toxicity and Eliminates the Systemic Cryptococcus neoformans Infection in Leukopenic Mice.

Authors:  Masood Alam Khan; Arif Khan; Mohd Azam; Khaled S Allemailem; Faris Alrumaihi; Ahmad Almatroudi; Fahad A Alhumaydhi; Faizul Azam; Shaheer Hasan Khan; Syeda Fauzia Farheen Zofair; Sumbul Ahmad; Hina Younus
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

4.  Effect of different levels of hydrolysable tannin intake on the reproductive hormones and serum biochemical indices in healthy female rats.

Authors:  Faiza Manzoor; Mahr Un Nisa; Hafiz Amjad Hussain; Nazir Ahmad; Huma Umbreen
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

5.  Antioxidant and Antimicrobial Activity of Cleomedroserifolia (Forssk.) Del. and Its Biological Effects on Redox Status, Immunity, and Gut Microflora.

Authors:  Nesrein M Hashem; Mohamed G Shehata
Journal:  Animals (Basel)       Date:  2021-06-28       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.